PKU care guidelines and how they affect daily well-being
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have PKU and are age 10 or older
- You need dietary treatment and and/or medicine for PKU based on your clinic’s guidelines
- You can understand and complete study questionnaires and follow study steps
- You (and the parent, if applicable) can provide signed consent to join
- You are not planning a pregnancy soon (and you are not pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition affects risk factors in adults with PKU (a condition that requires a special diet to control certain blood chemicals). If you can manage your diet independently and agree to follow the study diet plan, this may help researchers find better nutritional approaches.
This study looks at how taking Palynziq affects your nutrition and health in people with phenylketonuria (PKU). You might benefit by getting careful monitoring while researchers learn how the medicine changes diet-related measurements.
This study tests whether a specific mix of large neutral amino acids (LNAAs) can help adults with classical PKU by lowering phenylalanine levels in the brain. It includes an MRI and PET scan to see how the treatment affects brain activity.
This trial tests a one-time gene therapy called NGGT002 for adults with classic PKU who cannot take or do not respond well to current treatments. The goal is to see if it can safely lower blood phenylalanine levels.
This study looks at eating habits and disorders in people with phenylketonuria (PKU) who are treated at a specific hospital in Nancy, France. Participating involves sharing information, which may help doctors better understand eating challenges in PKU.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
Hear when a new Phenylketonurias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.